You are here
FDA warns researchers on claims of drug to detect brain disease
THE developers of a new drug aimed at diagnosing chronic traumatic encephalopathy, the degenerative brain disease linked to repeated head trauma, are under scrutiny by the US Food and Drug Administration.
In February, the FDA's Office of Prescription Drug Promotion sent a
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org